2023年年报点评:业绩同比反弹显著,追求综合发展提升长期竞争力
CMSKCMSK(SZ:001979) EBSCN·2024-03-25 16:00

Investment Rating - The report maintains a "Buy" rating for the company [9]. Core Insights - The company experienced a significant rebound in performance, with a notable improvement in profitability margins. The total revenue for 2023 was CNY 1750.1 billion, a decrease of 4.4% year-on-year, primarily due to a 7.0% decline in development business revenue to CNY 1539.6 billion. However, revenue from asset operations and urban services grew by 40.6% and 14.4%, respectively [1][2]. - The net profit attributable to the parent company reached CNY 63.2 billion, marking a year-on-year increase of 48.2%. This growth was partly due to a low base from the previous year and a significant reduction in asset impairment losses and credit impairment losses [1][2]. - The company has successfully deepened its presence in high-tier cities, ranking first in sales in Shanghai, Suzhou, Hefei, Changsha, and Nantong. The total sales amount for 2023 was CNY 2936 billion, a slight increase of 0.4% year-on-year [1][2]. - The company focused on acquiring high-quality land reserves, with a total of 55 land parcels acquired at a total cost of approximately CNY 1134 billion, achieving a land acquisition sales ratio of 38.6% [1][2]. - Financially, the company improved its structure, with cash and cash equivalents amounting to CNY 882.9 billion, a 2.4% increase year-on-year, and a net debt ratio of 54.6% [1][2]. Summary by Sections Revenue Performance - The company reported total revenue of CNY 1750.1 billion for 2023, down 4.4% from the previous year. The revenue growth rate was -4.37% [3][4]. Profitability - The net profit for 2023 was CNY 63.2 billion, reflecting a 48.2% increase year-on-year. The diluted EPS for 2023 was CNY 0.65, with a ROE of 5.3% [3][4]. Sales and Market Position - The company achieved sales of CNY 2936 billion in 2023, maintaining a strong position in high-tier cities, with a focus on balanced development in profit, quality, and efficiency [1][2]. Financial Health - The company held CNY 882.9 billion in cash, with a cash-to-short-term debt ratio of 1.28. The comprehensive funding cost was reduced to 3.47%, down 42 basis points from the beginning of the year [1][2].

CMSK-2023年年报点评:业绩同比反弹显著,追求综合发展提升长期竞争力 - Reportify